We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+46.89%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
+$351M
Cap. Flow
+$70.1M
Cap. Flow %
4.19%
Top 10 Hldgs %
34.79%
Holding
547
New
45
Increased
181
Reduced
257
Closed
36

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.8M
2
NVDA icon
NVIDIA
NVDA
+$8.71M
3
AAPL icon
Apple
AAPL
+$8.26M
4
SNDK
Sandisk
SNDK
+$7.29M
5
MRVL icon
Marvell Technology
MRVL
+$5.44M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$8.15M
2
GLD icon
SPDR Gold Trust
GLD
+$7.23M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$6.88M
4
AZN icon
AstraZeneca
AZN
+$5.05M
5
BTI icon
British American Tobacco
BTI
+$2.74M

Sector Composition

Rank Sector Weight
1 Technology 47.74%
2 Healthcare 19.17%
3 Communication Services 9.91%
4 Consumer Discretionary 7.67%
5 Consumer Staples 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTES icon
126
NetEase
NTES
$76.5B
$2.13M 0.13%
16,600
– –
HONA
127
Honeywell Aerospace
HONA
$64.7B
$2.11M 0.13%
+9,540
New +$2.1M
ROST icon
128
Ross Stores
ROST
$76.6B
$2.06M 0.12%
9,700
+601
+7% +$135K
CTAS icon
129
Cintas
CTAS
$82.4B
$2.05M 0.12%
12,047
+798
+7% +$138K
ADSK icon
130
Autodesk
ADSK
$44.3B
$2.01M 0.12%
10,353
-1,511
-13% -$345K
WBD icon
131
Warner Bros
WBD
$64.6B
$2.01M 0.12%
75,490
+5,729
+8% +$155K
TMO icon
132
Thermo Fisher Scientific
TMO
$211B
$2.01M 0.12%
4,000
+800
+25% +$384K
AXSM icon
133
Axsome Therapeutics
AXSM
$12.4B
$2M 0.12%
8,190
-888
-10% -$193K
MDGL icon
134
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.97M 0.12%
3,669
-602
-14% -$308K
SMMT icon
135
Summit Therapeutics
SMMT
$10.9B
$1.95M 0.12%
133,527
-4,069
-3% -$72.2K
CAT icon
136
Caterpillar
CAT
$409B
$1.94M 0.12%
1,818
+485
+36% +$426K
PCAR icon
137
PACCAR
PCAR
$69.6B
$1.9M 0.11%
15,847
+1,053
+7% +$124K
STM icon
138
STMicroelectronics
STM
$46B
$1.87M 0.11%
25,000
+7,000
+39% +$421K
CVS icon
139
CVS Health
CVS
$137B
$1.86M 0.11%
18,000
+2,000
+13% +$179K
CYTK icon
140
Cytokinetics
CYTK
$11B
$1.84M 0.11%
21,577
-279
-1% -$20K
NBIS
141
Nebius Group N.V.
NBIS
$47.7B
$1.83M 0.11%
+6,636
New +$1.31M
ARWR icon
142
Arrowhead Research
ARWR
$12.1B
$1.83M 0.11%
22,417
-2,433
-10% -$180K
RKLB icon
143
Rocket Lab Corp
RKLB
$39.9B
$1.77M 0.11%
+17,426
New +$1.74M
BMRN icon
144
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.76M 0.11%
30,761
-3,368
-10% -$184K
KRYS icon
145
Krystal Biotech
KRYS
$9.88B
$1.74M 0.1%
4,692
-495
-10% -$148K
ABBV icon
146
AbbVie
ABBV
$458B
$1.74M 0.1%
6,913
+1,880
+37% +$404K
BNTX icon
147
BioNTech
BNTX
$22.6B
$1.72M 0.1%
18,495
-1,735
-9% -$163K
FAST icon
148
Fastenal
FAST
$54B
$1.66M 0.1%
34,568
+2,265
+7% +$103K
BKR icon
149
Baker Hughes
BKR
$56.8B
$1.66M 0.1%
29,871
+2,071
+7% +$131K
NAMS icon
150
NewAmsterdam Pharma
NAMS
$3.47B
$1.65M 0.1%
48,605
+4,902
+11% +$162K
4 5
6
7 8

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return

China Universal Asset Management Company's Q2 2026 Portfolio in Review

As of Q2 2026, China Universal Asset Management Company held 547 positions worth $1.67B, up 27% from $1.32B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company deployed $70.1M of net new capital in Q2 2026, opening 45 new positions and adding to 181 existing holdings. Its largest new stake was Onto Innovation: 10,200 shares worth $3.86M.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was iShares Gold Trust, an estimated $8.15M trimmed.

  • China Universal Asset Management Company's largest Q2 2026 buy was Onto Innovation: 10,200 shares worth $3.86M.
  • China Universal Asset Management Company added most to Amazon in Q2 2026, an estimated $11.8M increase.
  • China Universal Asset Management Company's biggest Q2 2026 reduction was iShares Gold Trust, cutting an estimated $8.15M.
  • China Universal Asset Management Company fully exited AstraZeneca in Q2 2026, selling an estimated $5.05M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $1.67B portfolio in Q2 2026.
  • China Universal Asset Management Company opened 45 new positions and closed 36 in Q2 2026.
  • China Universal Asset Management Company's portfolio value rose 27% quarter-over-quarter to $1.67B.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.